Benjamin Titz

Co-Founder & CEO, AlkyonTx | Radiopharma | Medical Physics | Imaging & Dosimetry-Driven Development

Role
VP, Corporate Development at Lynx Biosciences, Inc
Location
San Diego, CA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Benjamin Titz

Co-founder and CEO of Alkyon Therapeutics, developing next-generation targeted radiotherapeutics for solid tumors using an imaging- and dosimetry-driven approach.Over 20 years of experience in radiopharmaceutical and radioligand therapy development, spanning preclinical research through IND clearance and first-in-human studies, including clinical trial initiation and integration of imaging, pharmacokinetics, and dosimetry to guide dose optimization and patient selection.Previously involved in the development of CLR131 and CLR124 at Cellectar Biosciences as an inventor, with contributions spanning IND-enabling work through early clinical execution (first-in-human), including securing $2.3M in NCI SBIR funding support and Orphan Drug Designation. European-trained with a U.S. PhD in Medical Physics.

Experience

  1. VP, Corporate Development

    Lynx Biosciences, Inc

    Mar 2019 — Present · San Diego, CA, US

Education

  • Technische Hochschule Mittelhessen

    BEng, Biomedical Engineering

  • Technische Hochschule Mittelhessen

    MEng, Biomedical Engineering

  • University of Wisconsin-Madison

    PhD, Medical Physics

  • University of Wisconsin-Madison

    MSc, Medical Physics

Skills

  • Data Analysis
  • Healthcare
  • Tumor Modeling
  • Business Strategy
  • Targeted Therapies
  • Strategy
  • Biomedical Engineering
  • Cancer Therapeutics
  • In Vivo
  • R&D
  • Matlab
  • Medical Devices
  • Clinical Research
  • Image Analysis
  • Imaging Biomarkers
  • Life Sciences
  • Positron Emission Tomography
  • Image Processing
  • Biotechnology
  • Drug Development
  • Pk/Pd Modeling
  • Cancer
  • Radiation Safety
  • Radiation Biology
  • Data Mining
  • Science
  • Mri
  • Competitive Analysis
  • Start-Ups
  • Radiation Therapy
  • Due Diligence
  • Physics
  • Medical Imaging
  • Molecular Imaging
  • Simulations
  • Radiation
  • Strategic Planning
  • Medical Physics
  • Oncology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Benjamin Titz — VP, Corporate Development at Lynx Biosciences, Inc in San Diego, CA, US | Unifers